A comprehensive industry overview and market perspective are included in the latest study from MarkNtel Advisors titled Global Cancer Gene Panel and Profiling Market. The research provides a detailed overview of the current market state, including market trends and the most recent advancements made globally. In-depth analysis of market size, share, industry trends, forecast, and competitive environment is covered in the report that presents clear picture of the market with relevant statistical data.
The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.
Global Cancer Gene Panel and Profiling Market Definition:
Cancer gene panel & profiling is a genetic testing method that focuses on analyzing a specific set of genes associated with a particular condition or disease. It involves sequencing & analyzing the DNA within these selected genes to identify potential variations, mutations, or alterations that may be linked to the condition under investigation. Gene profiling testing refers to the comprehensive analysis of multiple genes or gene expression patterns to gain insights into various biological processes, disease states, or responses to treatments. Both gene panel testing & gene profiling testing play crucial roles in genomics research, personalized medicine, and clinical diagnostics by providing insights into genetic variations, gene expression patterns, and their implications for health and disease.
Request Sample Report- https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html
Global Cancer Gene Panel and Profiling Market Insights:
The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29.
Global Cancer Gene Panel and Profiling Market Driver:
Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.
Also, genetic testing companies have started offering a comprehensive array of services, including advanced screening & diagnostics in recent years. As a result, there has been an increasing adoption of these testing services by research institutions & clinical laboratories engaged in detecting biomarkers of hereditary cancer cases. This robust adoption trajectory is a direct response to the persistent surge in hereditary cancer cases, as evidenced by historical trends. For instance:
In 2022, the National Cancer Institute indicated that approximately 10% of all cancer cases witnessed were attributable to hereditary genetic mutations.
As the mutations in hereditary cancer are only pinpointed to specific genes responsible for shielding the body against cancer, it led to genetic testing services coming up as a pivotal method of diagnosis. Notably, clinicians have embraced this technique with significant impact, thereby fostering substantial growth within the Cancer Gene Panel and Profiling Market.
Global Cancer Gene Panel and Profiling Market Leading Key Players:
10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other
Browse Full Report – https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html
Global Cancer Gene Panel and Profiling Market Segmentation:
Based on Technology
– Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million
– Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million
– Microarray- Market Size & Forecast 2019-2029, USD Million
– Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million
– Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million
Based on Application
– Oncology Research- Market Size & Forecast 2019-2029, USD Million
– Personalized Medicine- Market Size & Forecast 2019-2029, USD Million
– Drug Development- Market Size & Forecast 2019-2029, USD Million
– Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million
Based on Cancer Type
– Breast Cancer- Market Size & Forecast 2019-2029, USD Million
– Lung Cancer- Market Size & Forecast 2019-2029, USD Million
– Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million
– Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million
– Others (Ovarian Cancer, Leukemia, etc.) – Market Size & Forecast 2019-2029, USD Million
Based on Cell Type
– Germline – Market Size & Forecast 2019-2029, USD Million
– Somatic – Market Size & Forecast 2019-2029, USD Million
Based on End-User
– Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million
– Research Institutes- Market Size & Forecast 2019-2029, USD Million
– Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million
– Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million
Talk to our Consultant – https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-gene-panel-profiling-market.html
Global Cancer Gene Panel and Profiling Market Geographical Analysis
By Region
– North America
– South America
– Europe
– The Middle East & Africa
– Asia-Pacific
Recent Development of Global Cancer Gene Panel and Profiling Market:
2023: Neo Genomics and Massive Bio announced a collaboration to leverage their expertise in biomarker testing, data analysis, machine learning, and biomarker and genomic profiling to accomplish a significant milestone within the field of oncology.
Request Customization – https://www.marknteladvisors.com/query/request-customization/cancer-gene-panel-profiling-market.html
About Us:
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact us:
If you have any questions, our team of trained and professional experts is here to help. You can get in touch with us by calling, sending an email, or using our online contact form.
We will try our best to answer your request as quickly as we can and give you the details you require.
Call: 
+1 628 895 8081, +91 120 4278433
Email: 
sales@marknteladvisors.com
Visit to know more: 
https://www.marknteladvisors.com/
